Skip to content

Home Map The News Technology Politics Business Sports Entertainment Science Health World

Global AI-Powered News Intelligence. Real-time headlines, mapped by continent and country, from news sources worldwide.

Powered by AI

Navigate

Home
Map The News
About
Sources & methodology
Sources & methodology
Search

Sections

Technology
Politics
Business
Sports
Entertainment
Science

More

Privacy
Contact
Sitemap
Robots

© 2026 newsGlobal. All rights reserved.

Headlines refresh every 10 minutes.

Home Map Search Topics About

Home / Business

Business

Bloomberg

BusinessBloomberg·Aug 19, 2026·1 min read

Merck, Moderna Melanoma Vaccine Study Succeeds

Merck and Moderna announced positive results from a large late-stage trial of their personalized mRNA cancer vaccine, which significantly reduced the recurrence of melanoma, the deadliest form of skin cancer. Madison Muller reports on…

View original source — Bloomberg ↗

ShareShare on X Share on Facebook

Related stories

Markets Rally After U.S. Treasury Tries to Ease Bond Market Stress

The New York Times

BusinessAug 19, 2026 · 1 min

Markets Rally After U.S. Treasury Tries to Ease Bond Market Stress

The New York Times

BusinessAug 19, 2026 · 1 min

TrueCar CEO Says Discounts Buoy 'Very Soft' Auto Market

BusinessAug 19, 2026 · 1 min

Target Raises Sales Outlook as Turnaround Gains Strength

Irish lawmakers summon TikTok over videos glorifying dangerous driving

BusinessAug 19, 2026 · 1 min

Irish lawmakers summon TikTok over videos glorifying dangerous driving